Literature DB >> 33363128

Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines.

Aldy Aliyandi1, Inge S Zuhorn2, Anna Salvati1.   

Abstract

Nanoparticles are promising tools for nanomedicine in a wide array of therapeutic and diagnostic applications. Yet, despite the advances in the biomedical applications of nanomaterials, relatively few nanomedicines made it to the clinics. The formation of the biomolecular corona on the surface of nanoparticles has been known as one of the challenges toward successful targeting of nanomedicines. This adsorbed protein layer can mask targeting moieties and creates a new biological identity that critically affects the subsequent biological interactions of nanomedicines with cells. Extensive studies have been directed toward understanding the characteristics of this layer of biomolecules and its implications for nanomedicine outcomes at cell and organism levels, yet several aspects are still poorly understood. One aspect that still requires further insights is how the biomolecular corona interacts with and is "read" by the cellular machinery. Within this context, this review is focused on the current understanding of the interactions of the biomolecular corona with cell receptors. First, we address the importance and the role of receptors in the uptake of nanoparticles. Second, we discuss the recent advances and techniques in characterizing and identifying biomolecular corona-receptor interactions. Additionally, we present how we can exploit the knowledge of corona-cell receptor interactions to discover novel receptors for targeting of nanocarriers. Finally, we conclude this review with an outlook on possible future perspectives in the field. A better understanding of the first interactions of nanomaterials with cells, and -in particular -the receptors interacting with the biomolecular corona and involved in nanoparticle uptake, will help for the successful design of nanomedicines for targeted delivery.
Copyright © 2020 Aliyandi, Zuhorn and Salvati.

Entities:  

Keywords:  biomolecular corona; cell receptors; corona-receptor interactions; nanoparticles; targeting; uptake

Year:  2020        PMID: 33363128      PMCID: PMC7758247          DOI: 10.3389/fbioe.2020.599454

Source DB:  PubMed          Journal:  Front Bioeng Biotechnol        ISSN: 2296-4185


  114 in total

1.  Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties.

Authors:  Rong Liu; Wen Jiang; Carl D Walkey; Warren C W Chan; Yoram Cohen
Journal:  Nanoscale       Date:  2015-06-07       Impact factor: 7.790

2.  Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro.

Authors:  Julia V Georgieva; Dharamdajal Kalicharan; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Dick Hoekstra; Inge S Zuhorn
Journal:  Mol Ther       Date:  2010-11-02       Impact factor: 11.454

3.  Super-Resolution Microscopy Unveils Dynamic Heterogeneities in Nanoparticle Protein Corona.

Authors:  Natalia Feiner-Gracia; Michaela Beck; Sílvia Pujals; Sébastien Tosi; Tamoghna Mandal; Christian Buske; Mika Linden; Lorenzo Albertazzi
Journal:  Small       Date:  2017-09-18       Impact factor: 13.281

4.  Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers.

Authors:  Susanne Schöttler; Greta Becker; Svenja Winzen; Tobias Steinbach; Kristin Mohr; Katharina Landfester; Volker Mailänder; Frederik R Wurm
Journal:  Nat Nanotechnol       Date:  2016-02-15       Impact factor: 39.213

5.  Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.

Authors:  Akin Akinc; William Querbes; Soma De; June Qin; Maria Frank-Kamenetsky; K Narayanannair Jayaprakash; Muthusamy Jayaraman; Kallanthottathil G Rajeev; William L Cantley; J Robert Dorkin; James S Butler; Liuliang Qin; Timothy Racie; Andrew Sprague; Eugenio Fava; Anja Zeigerer; Michael J Hope; Marino Zerial; Dinah W Y Sah; Kevin Fitzgerald; Mark A Tracy; Muthiah Manoharan; Victor Koteliansky; Antonin de Fougerolles; Martin A Maier
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

6.  Size and shape effects in the biodistribution of intravascularly injected particles.

Authors:  P Decuzzi; B Godin; T Tanaka; S-Y Lee; C Chiappini; X Liu; M Ferrari
Journal:  J Control Release       Date:  2009-10-27       Impact factor: 9.776

7.  Tuning liposome composition to modulate corona formation in human serum and cellular uptake.

Authors:  Keni Yang; Bárbara Mesquita; Peter Horvatovich; Anna Salvati
Journal:  Acta Biomater       Date:  2020-02-17       Impact factor: 8.947

Review 8.  The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.

Authors:  Valentina Francia; Raymond M Schiffelers; Pieter R Cullis; Dominik Witzigmann
Journal:  Bioconjug Chem       Date:  2020-08-31       Impact factor: 4.774

Review 9.  Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier.

Authors:  Julia V Georgieva; Dick Hoekstra; Inge S Zuhorn
Journal:  Pharmaceutics       Date:  2014-11-17       Impact factor: 6.321

10.  Unbiased Identification of the Liposome Protein Corona using Photoaffinity-based Chemoproteomics.

Authors:  Roy Pattipeiluhu; Stefan Crielaard; Iris Klein-Schiphorst; Bogdan I Florea; Alexander Kros; Frederick Campbell
Journal:  ACS Cent Sci       Date:  2020-04-01       Impact factor: 14.553

View more
  4 in total

1.  Identifying cell receptors for the nanoparticle protein corona using genome screens.

Authors:  Wayne Ngo; Jamie L Y Wu; Zachary P Lin; Yuwei Zhang; Bram Bussin; Adrian Granda Farias; Abdullah M Syed; Katherine Chan; Andrea Habsid; Jason Moffat; Warren C W Chan
Journal:  Nat Chem Biol       Date:  2022-08-11       Impact factor: 16.174

2.  Influence of Critical Parameters on Cytotoxicity Induced by Mesoporous Silica Nanoparticles.

Authors:  Amirsadra Ahmadi; Moses Sokunbi; Trisha Patel; Ming-Wei Chang; Zeeshan Ahmad; Neenu Singh
Journal:  Nanomaterials (Basel)       Date:  2022-06-11       Impact factor: 5.719

3.  Magneto-mechanical treatment of human glioblastoma cells with engineered iron oxide powder microparticles for triggering apoptosis.

Authors:  C Thébault; M Marmiesse; C Naud; K Pernet-Gallay; E Billiet; H Joisten; B Dieny; M Carrière; Y Hou; R Morel
Journal:  Nanoscale Adv       Date:  2021-09-28

Review 4.  Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation.

Authors:  Anna Salvati; Klaas Poelstra
Journal:  Pharmaceutics       Date:  2022-01-17       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.